H.R. 6101 · 117th Congress · House

Drug Price Transparency in Medicaid Act of 2021

Active· Referred to the Subcommittee on Health.
Introduced
Dec 1, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Drug Price Transparency in Medicaid Act of 2021

This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions, dispensing fees, and survey participation to be made publicly available.

Action Timeline

4
  1. DEC 02, 2021Committee

    Referred to the Subcommittee on Health.

  2. DEC 01, 2021IntroReferral

    Introduced in House

  3. DEC 01, 2021IntroReferral

    Introduced in House

  4. DEC 01, 2021IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: Dec 2, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Dec 1, 2021

Active